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icaid (MediCal) program. METHODS: A retrospective
study was conducted by using claims data from January
1995 to December 2000. Dependent variables were total
healthcare cost, the occurrence of event, and time to
event. Event included hospitalization or ER visits. His-
torical data including demographic factors, healthcare
cost and utilization, type of drugs, increasing dose,
adding drugs, changing drugs, follow-up services based
on diabetic guidelines (e.g., ofﬁce visit, lab tests, and self
glucose monitoring), medication compliance, complica-
tions, and comorbidity were used as independent vari-
ables. The generalized estimating equation and the ﬁxed
effect partial likelihood methods were used in a longitu-
dinal data set and a cross-sectional data set with repeat-
able events, respectively. RESULTS: Older age was related
to an increase in patient risk. Healthcare cost and uti-
lization in the previous period had a signiﬁcant positive
impact on patient risk in the next period. Patients taking
both insulin and oral hypoglycemic drugs and patients
having oral hypoglycemic or anti-hypertensive drugs
added into the regimen were positively associated with an
increase in patient risk. However, medication compliance
was negatively related to an increase in patient risk.
Follow-up services based on diabetic guidelines factors
(i.e., having ofﬁce visit, having glucose monitoring strip,
having HbA1C test) were negatively associated with an
increase in patient risk. Comorbidity factors (i.e., hyper-
tension and hyperlipidemia) and three complication
factors (i.e., retinopathy, nephropathy and foot infection)
were positively related to patient risk. CONCLUSIONS:
Factors associated with high-risk diabetic patients could
help healthcare providers and administrators intervene to
improve patient outcomes.
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OBJECTIVES: There is increasing concern that rising
drug costs may make prescription drugs unaffordable to
seniors and therefore a need for Medicare prescription
beneﬁts coverage. The objective of this study was to assess
prescription drug use patterns and expenditure of diabetic
Medicare beneﬁciaries with supplemental private insur-
ance with and without prescription beneﬁts. METHODS:
The 1999 Medical Expenditure Panel Survey (MEPS) pro-
vided the data for the study. Medicare diabetics with sup-
plemental private insurance coverage were identiﬁed, and
those with and without prescription beneﬁts separated
into two groups. Descriptive statistics for the two groups
were determined and t-test used to compare differences
in age, education, income, number of diabetes related pre-
scriptions, total drug and out of pocket drug expenditures
related to diabetes, and number of comorbidities.
RESULTS: A total of 453 Medicare diabetics were iden-
tiﬁed from a total of 24,618 MEPS respondents with 186
(39.4%) reporting supplemental private insurance. Of
these, 103 (55.4%) reported drug coverage. Those with
and without drug coverage did not differ signiﬁcantly
with respect to age but education was signiﬁcantly dif-
ferent (p = 0.04) with those having coverage being more
educated. Income differed but did not reach statistical sig-
niﬁcance (p = 0.053). The two cohorts did not differ sig-
niﬁcantly in terms of total number of diabetes-related
prescriptions and both total and out of pocket expendi-
tures. However, out of pocket cost for those without 
prescription coverage averaged about 76% of total drug
expenditure while it averaged 53% for those with cover-
age. CONCLUSIONS: In the MEPS data, Medicare dia-
betics with supplemental private insurance coverage with
and without prescription beneﬁts did not differ in terms
of diabetes related prescription use and expenditure.
However, those with out drug coverage who had a lesser
mean income ($15,670) incurred a higher percentage of
out of pocket drug cost than those with coverage and who
had a higher mean income ($19,199).
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